改善心肌肌质网钙泵防治慢性心力衰竭的中医药研究进展
李惠玲 贾美君 刘永明
上海中医药大学附属曙光医院心血管内科,上海 201203
Research progress on improving myocardial sarcoplasmic reticulum calcium ATPase 2a with the treatment of traditional Chinese medicine in chronic heart failure
LI Huiling JIA Meijun LIU Yongming
Department of Cardiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
摘要 慢性心力衰竭(CHF)是多种心血管疾病发展的终末阶段,发病率及病死率高,治疗费用昂贵。心肌细胞肌质网钙泵(SERCA2a)表达及活性异常是CHF发生、发展的重要病理机制。AAV1/SERCA2a转基因治疗CHF临床试验结果不尽如人意,研究者重新提出“应充分重视提高内源性心肌SERCA2a水平及活性的药物筛选及研发”。中医药治疗CHF历史悠久,效果显著。CHF在中医学中可归属于“心悸”“喘证”“水肿”等范畴。大量研究表明中药复方、单味中药、中药单体能有效改善内源性心肌SERCA2a表达水平及活性从而起到防治CHF的作用。
关键词 :
慢性心力衰竭 ,
肌质网钙泵 ,
蛋白表达 ,
基因表达 ,
活性
Abstract :Chronic heart failure (CHF ) is the end stage of a variety of cardiovascular diseases, with high incidence, high mortality and expensive treatment. The abnormal expression and activity of cardiac myocyte sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) are the key pathological mechanism for the occurrence and development of CHF. The results of the clinical trial that AAV1/SERCA2a genetically treats CHF were not satisfactory, and the researchers restated that full attention should be paid to drug screening, research and development to improve the endogenous myocardial SERCA2a expression level and activity. Traditional Chinese medicine has a long history in treating CHF with remarkable therapeutic effects. In traditional Chinese medicine, CHF can be classified to the cotogories of "palpitation", "asthma syndrome" and "edema". A lot of researches indicate that Chinese medicine compound, single Chinese herb and Chinese medicine monomer can prevent and treat CHF through improving endogenous myocardial SERCA2a expression and activity.
Key words :
Chronic heart failure
Sarcoplasmic reticulum calcium ATPase 2a
Protein expression
Gene expression
Activity
基金资助: 国家自然科学基金资助项目(81102671);
上海市卫生和计划生育委员会项目资助(201640167);
国家自然科学基金资助项目(81603581)。
通讯作者:
刘永明(1973.2-),女,博士,副主任医师,硕士研究生导师;研究方向:中西医结合防治心血管疾病。
作者简介 : 李惠玲(1990.9-),女,上海中医药大学附属曙光医院2017级中西医结合临床专业在读硕士研究生;研究方向:中西医结合防治心血管疾病。
[1] Mora MT,Ferrero JM,Romero L,et al. Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure [J]. PLoS One,2017,12(11):e0187739.
[2] Sacchi V,Wang BJ,Kubli D,et al. Peptidyl-Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+ Exchanger 1 Protein Levels and Function [J]. J Am Heart Assoc,2017,6(10):e006837.
[3] Gorski PA,Ceholski DK,Hajjar RJ. Altered myocardial calcium cycling and energetics in heart failure--a rational approach for diseasetreatment [J]. Cell Metab,2015,21(2):183-194.
[4] Hu LR,Ackermann MA,Hecker PA,et al. Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin [J]. Sci Adv,2017,3(6):e1603081.
[5] 刘永明,徐裕亚,那木海,等.坎离颗粒对压力负荷超载所致舒张性心衰大鼠心肌肌浆网钙转运的影响[J].中医杂志,2015,56(21):1867-1870.
[6] Wang Q,Liu Y,Fu Q,et al. Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction [J]. Circulation,2017,135(1):73-88.
[7] Silveira CFSMP,Campos DHS,Freire PP,et al. Importance of SERCA2a on early isolated diastolic dysfunction induced by supravalvular aortic stenosis in rats [J]. Braz J Med Biol Res,2017,50(5):e5742.
[8] Jaski BE,Jessup ML,Mancini DM,et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease(CUPID Trial),a First-in-Human Phase 1/2 Clinical Trial [J]. J Card Fail,2009,15(3):171-181.
[9] Hulot JS,Salem JE,Redheuil A,et al. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure:results from the AGENT-HF randomized phase 2 trial [J]. Eur J Heart Fail,2017,19(11):1534-1541.
[10] Greenberg B,Butler J,Felker GM,et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease(CUPID 2):a randomized,multinational,double-blind,placebo-controlled,phase 2b trial [J]. Lancet,2016,387(10024):1178-1186.
[11] 连志明,权力,刘明鑫,等.稳心颗粒对心力衰竭兔心肌细胞肌浆网钙泵基因和蛋白表达的影响[J].中国心脏起搏与心电生理杂志,2014,28(6):527-531.
[12] 郭志华,吴刚强,申思,等.益心泰对慢性心力衰竭大鼠心肌钙超载及肌浆网钙泵的影响[J].中国中医药现代远程教育,2013,3(155):157-159.
[13] 吴锦波,叶小汉,冼绍祥,等.中药心康方对心力衰竭大鼠心肌miR-25-3p表达水平和SERCA2a活性的影响[J].中国病理生理杂志,2016,32(10):1770-1774.
[14] Yu X,Zhao XD,Bao RQ,et al. The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats [J]. BMC Complement Altern Med,2017, 17(1):330.
[15] 青楚杭.芪苈强心提取物下调microRNA-25改善缺氧诱导的心肌细胞损伤[D].南充:川北医学院,2017.
[16] 苗梦露,李七一,严士海,等.抗心衰颗粒对舒张性心衰大鼠模型心肌细胞内钙离、ATP酶及心肌线粒体超微结构的影响[J].北京中医药大学学报,2013,36(7):468-471.
[17] 张萍,王海云,苏博,等.延胡索提取物对AMI大鼠模型心肌梗死面积及Na+-K+-ATPase、Ga2+-ATPase活性的影响[J].中西医结合心脑血管病杂志,2017,15(4):410-415.
[18] Dong Z,Zhao P,Xu M,et al. Astragaloside Ⅳ alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation [J]. Sci Rep,2017,7(1):2691.
[19] Bai T,Hu X,Zheng Y,et al. Resveratrol protects against Lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization [J]. Am J Physiol Heart Circ Physiol,2016,311(4):H1051-H1062.
[20] 戴红良,贾桂枝,赵颂,等.黄芪多糖对异丙肾上腺素诱发的SERCA2a表达及活性降低的影响[J].中国药理学通报,2015,31(3):388-391.
[21] 王俊东,崔勇,王建国,等.人参皂苷Rh3预处理对心肌缺血再灌注损伤大鼠心肌肌浆网Ca2+-ATP酶表达的影响[J].中华老年心脑血管病杂志,2016,18(10):1077-1081.
[22] 王金桂,祝宝华,于晓頔,等.前胡丙素对大鼠缺血-再灌注心肌肌浆网钙泵功能及其蛋白水平的影响[J].江苏医药,2015,41(2):138-141.
[23] Wu X,Xu T,Li D,et al. ERK/PP1a/PLB/SERCA2a and JNK Pathways Are Involved in Luteolin-Mediated Protection of Rat Hearts and Cardiomyocytes following Ischemia/Reperfusion [J]. PLoS One,2013,8(12):e82957.
[24] Du Y,Liu P,Xu T,et al. Luteolin Modulates SERCA2a Leading to Attenuation of Myocardial Ischemia/Reperfusion Injury via Sumoylation at Lysine 585 in Mice [J]. Cell Physiol Biochem,2018,45(3):883-898.
[1]
周艳丽1 王大利2 张艳1 张宁1 李硕熙1 吴娇3 李杨3. 三花龙胆化学成分及抗肿瘤活性研究 [J]. 中国医药导报, 2019, 16(1): 20-23.
[2]
田小超1 何伟亮2. 胺碘酮联合养心定悸胶囊对慢性心力衰竭合并室性早搏患者心功能及血管内皮功能的影响 [J]. 中国医药导报, 2018, 15(8): 40-43.
[3]
张文书 向静 黄欧佳. 慢性心力衰竭患者的希望水平与焦虑抑郁水平及应对方式相关性分析 [J]. 中国医药导报, 2018, 15(8): 56-59.
[4]
郇科1,2 白博1 白晓智3 苏菲1 陈潇4 桑宏勋1,5. 新型纳米晶体银锌敷料对大鼠深Ⅱ度烫伤感染创面的疗效 [J]. 中国医药导报, 2018, 15(6): 4-7.
[5]
方慧 刘琪. 牙周炎与活性氧致病机制的研究进展 [J]. 中国医药导报, 2018, 15(5): 22-26.
[6]
袁志坚 何文涓 胡晶▲. 吴茱萸次碱药理学研究进展 [J]. 中国医药导报, 2018, 15(36): 40-43.
[7]
袁伟曦 刘海平 曹顺旺 余丰 陈文芳 刘丽雅. 常见金属离子对鲍曼不动杆菌生物活性的影响 [J]. 中国医药导报, 2018, 15(35): 47-49,57.
[8]
苏海燕1 王克隆2. 注射用益气复脉联合他汀类药物治疗慢性心力衰竭合并心房颤动的临床效果 [J]. 中国医药导报, 2018, 15(35): 70-73.
[9]
李国倩1,2 秦天3 黄蓉1,2 唐祥1,2 杨春艳1,2 周春阳1,2. 文冠果果壳醇提物不同部位总多酚含量及其抗氧化活性研究 [J]. 中国医药导报, 2018, 15(34): 27-31,36.
[10]
林彤 沙永强 陈泽雄. 中药活性成分诱导肝细胞癌自噬的体外实验研究进展 [J]. 中国医药导报, 2018, 15(34): 49-52,56.
[11]
王婷婷1,2 王桂香1,2 张俊绘2 刘爱菊2. miRNA let-7对疾病调控机制的研究进展 [J]. 中国医药导报, 2018, 15(34): 53-56.
[12]
杜春雨 王佳贺▲. 中药抑制金黄色葡萄球菌的研究进展 [J]. 中国医药导报, 2018, 15(31): 64-67.
[13]
李燕 黄凌波 付兵 杨智 赵志勇 王波. 磁共振评价慢性心力衰竭患者右心结构及功能的临床研究 [J]. 中国医药导报, 2018, 15(31): 135-137.
[14]
宗宪磊1 曹春艳1 宋国栋1 赖晨智1 余泮熹1 靳小雷1 姜笃银2,3. 角质细胞生长因子活性短肽促进糖尿病大鼠创面愈合的实验研究 [J]. 中国医药导报, 2018, 15(30): 4-7.
[15]
潘瑞1 杜业亮2▲ 牟伟男1 刘琦慧1 赵宇1. 蛛网膜下腔出血后脑心综合征大鼠体内肾素-血管紧张素的变化 [J]. 中国医药导报, 2018, 15(24): 18-21.